ReproCELL News

Hatena, Minkabu the Infonoid, etc.

＜175A＞Will SMART Co., Ltd. Zenrin Co., Ltd. Stock Ownership Ratio -% → 44.67% Reporting Obligation Date 2024/04/16 ＜2586＞Frutta Fruta Evo Fund Co., Ltd. Stock Ownership Ratio 40.49% → 40.02% Reporting Obligation Occurrence Date 2024/04/12 ＜3930＞Hatena Co., Ltd. SBI Securities Stock Ownership Ratio 5.09% → 1.80% Report

Fisco JapanApr 22 08:17

Is push buying dominant due to steady growth and expectations of a drop in US interest rates

[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop steadily. In the US stock market yesterday 3rd, the Dow Average continued to fall slightly for 3 days to 39127.14 dollars, which depreciated by 43.10 dollars (-0.11%). ADP employment statistics exceeded expectations, and the view that interest rate cuts were even farther away weighed on stock prices. Meanwhile, in addition to the unexpected decline in the March ISM non-manufacturing business climate index, Chairman Powell of the Federal Reserve (Fed) continues to suggest the possibility of interest rate cuts by the end of the year

Fisco JapanApr 4 07:20

LaQuoria Drug Discovery, Reprocel, etc.

＜3195＞Genepa launches a new business (Unique Stores Platform business) ＜4579＞LaQuolia Pharmaceutical signed an agreement with Velovia Pharma, LLC (US) on the development of pet pharmaceuticals ＜4978＞Reprocel research and development business “Research and development to begin corporate clinical trials of cell therapy using cell transplantation of human iPS cell-derived glial progenitor cells (iRP) for amyotrophic lateral sclerosis (ALS)” ANED Public Recruitment Project “Regenerative Medicine

Fisco JapanApr 4 06:30

ReproCELL 9-Mos Net Y48.00M Vs Loss Y39.00M

ReproCELL Inc. (4978.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y1.78 bln Y2.22 bln Operating Profit (Y28

Dow JonesFeb 9 14:02

ReproCELL 1H Net Y60.00M Vs Net Y68.00M

ReproCELL Inc. (4978.TO) Japan 1st Half Ended September 30 GROUP 2023 2022 Revenue Y1.15 bln Y1.58 bln Operating Profit (Y241.00 mln)

Dow JonesNov 10, 2023 14:03

ReproCELL Sees FY Net Y148.00M

ReproCELL Inc. also released the following forecasts: GROUP Year Ending Mar 2024 Revenue Y3.05 bln Operating Profit (Y110.00 mln) Pretax Pro

Dow JonesAug 10, 2023 14:03